末梢液体塞栓薬の世界市場

末梢液体塞栓薬の世界市場は2030年までに6,450万米ドルに達する見込み

2024年に4,280万米ドルと推定される末梢液体塞栓薬の世界市場は、分析期間2024-2030年にCAGR 7.1%で成長し、2030年には6,450万米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるチューブアプリケーター/インサーターは、CAGR 5.7%を記録し、分析期間終了時には3,840万米ドルに達する見込みです。鼓膜切開チューブセグメントの成長率は、分析期間中CAGR 9.3％と推定されます。

米国市場は1,170万米ドルと推定、中国はCAGR 10.8％で成長予測

米国の末梢液体塞栓薬市場は、2024年には1,170万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024年から2030年にかけてCAGR 10.8%で推移し、2030年には1,330万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.6%と6.8%と予測されています。欧州では、ドイツがCAGR 4.6%で成長すると予測されています。

世界の末梢液体塞栓薬市場- 主要動向と促進要因まとめ

複雑な血管閉塞に液体塞栓薬が有効な理由とは？

末梢液体塞栓薬は、その場で固化することで血管を閉塞させ、異常または病的な血管系の血流を遮断するために使用される注射可能な化合物です。これらの薬剤は、コイルの展開が不十分な高流量または不規則な血管構造への対応に特に有効です。蛇行した血管や微小血管の隙間を埋めることができるため、動静脈奇形、出血性腫瘍、エンドリークの治療に有用です。

液体塞栓は透視下、マイクロカテーテルを通して投与されます。一旦標的血管内に入ると、物理的または化学的変化-重合、沈殿、凝固-を起こし、耐久性のある閉塞を形成します。非標的塞栓を防ぎ、治療結果を最適化するためには、粘度、流動性、固化時間のコントロールが重要です。

材料と送達システムはどのように治療成績を向上させているか？

液体塞栓剤には現在、シアノアクリレート、エチレンビニルアルコール、その他のポリマーベースの製剤があります。放射線透過性の改善により、手技の可視性が向上しました。また、注入力を軽減し、展開時の均一性を高める添加剤を組み込んだ薬剤もあります。また、包装の革新やプレフィルドシリンジにより、準備時間が短縮され、無菌的な取り扱いが可能になりました。

デリバリーシステムは、二重管腔カテーテル、逆流防止設計、圧力制御注射器などの開発により進歩しています。これらのツールは、インターベンショニストに送達時のより高い精度とコントロールを提供します。毒性を低減し、生体適合性を向上させ、微小血管への選択的な浸透を可能にする努力は、特に繊細な解剖学的構造または小児患者を含む症例において継続中です。

どのような臨床現場が市場の需要を牽引しているか？

病院や専門的なインターベンショナル・ラジオロジー・センターが液体塞栓薬の主要ユーザーです。腫瘍センターでは、手術や切除の前に腫瘍の脈管形成を阻害するために使用されます。また、消化管出血、腎動脈出血、骨盤外傷の治療にも不可欠です。神経血管処置での使用は確立されており、末梢血管系への応用も着実に拡大しています。

高度な血管内治療に投資している地域では需要が伸びています。非伝染性疾患の罹患率の上昇、人口の高齢化、専門医による治療へのアクセスの向上が成長の原動力となっています。塞栓術を外来やデイケアのプロトコールに組み込むことも、手技量の増加や液体薬剤の採用に寄与しています。

末梢液体塞栓薬市場の成長はいくつかの要因によってもたらされる...

末梢液体塞栓薬市場の開拓は、末梢血管異常の発生率の増加、インターベンショナル腫瘍学および外傷管理における用途の拡大、先進塞栓製剤の継続的な開発によってもたらされます。低侵襲な塞栓術への嗜好の高まりが、緊急治療と選択的治療の両方における採用率の上昇を後押ししています。

カテーテル送達システムの技術的改良、画像互換性の向上、専門的インターベンショナルサービスの幅広い利用可能性が、手技の効率化と臨床的信頼性の向上に寄与しています。高流量病変、脆弱な血管系、腫瘍血管系に合わせた塞栓剤の開発は、多様な臨床場面での使用をさらに後押ししています。ヘルスケアのインフラと専門家養成の成長により、世界の使用拡大が期待されます。

セグメント

製品（チューブアプリケーター/インサーター、鼓膜切開チューブ）、素材（シリコン素材、フッ素樹脂素材、チタン素材、ステンレススチール素材）、用途（急性中耳炎用途、滲出性中耳炎再発用途）、最終用途（病院最終用途、外来手術センター最終用途、専門クリニック最終用途）

調査対象企業の例

• Abbott Laboratories
• Acandis GmbH
• Balt
• Boston Medical Corporation
• Cardiva
• Cook Medical LLC
• Cerenovus（J&J）
• IMBiotechnologies Ltd.
• Johnson & Johnson
• Kaneka Corporation
• Medtronic plc
• Merit Medical Systems
• Meril Life Sciences Pvt. Ltd.
• MicroVention Inc.（Terumo）
• Penumbra, Inc.
• Rapid Medical
• Stryker Corporation
• Terumo Corporation
• Sirtex Medical Limited

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Peripheral Liquid Embolic Agents Market to Reach US$64.5 Million by 2030

The global market for Peripheral Liquid Embolic Agents estimated at US$42.8 Million in the year 2024, is expected to reach US$64.5 Million by 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Tube Applicator / Inserter, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$38.4 Million by the end of the analysis period. Growth in the Tympanostomy Tubes segment is estimated at 9.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$11.7 Million While China is Forecast to Grow at 10.8% CAGR

The Peripheral Liquid Embolic Agents market in the U.S. is estimated at US$11.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$13.3 Million by the year 2030 trailing a CAGR of 10.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.6% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Global Peripheral Liquid Embolic Agents Market - Key Trends & Drivers Summarized

What Makes Liquid Embolic Agents Effective in Complex Vascular Occlusions?

Peripheral liquid embolic agents are injectable compounds used to occlude blood vessels by solidifying in situ, blocking blood flow in abnormal or diseased vasculature. These agents are particularly effective in addressing high-flow or irregular vascular structures where coil deployment is insufficient. Their ability to fill tortuous or microvascular spaces makes them useful in treating arteriovenous malformations, bleeding tumors, and endoleaks.

Liquid embolics are delivered through microcatheters under fluoroscopic guidance. Once inside the target vessel, they undergo physical or chemical transitions-polymerization, precipitation, or solidification-forming a durable occlusion. Control over viscosity, flow, and setting time is critical to prevent non-target embolization and optimize treatment outcomes.

How Are Materials and Delivery Systems Improving Procedure Outcomes?

Liquid embolic agents now include formulations based on cyanoacrylate, ethylene vinyl alcohol, and other polymer-based systems. Improvements in radiopacity enhance procedural visibility. Some agents incorporate additives that reduce injection force and increase uniformity during deployment. Packaging innovations and prefilled syringes also reduce preparation time and support aseptic handling.

Delivery systems have advanced through development of dual-lumen catheters, reflux-resistant designs, and pressure-controlled injection devices. These tools provide interventionalists with higher accuracy and control during delivery. Efforts to reduce toxicity, improve biocompatibility, and enable selective penetration of microvessels are ongoing, especially in cases involving sensitive anatomy or pediatric patients.

Which Clinical Settings Are Driving Market Demand?

Hospitals and specialized interventional radiology centers are primary users of liquid embolics. Oncology centers use these agents to devascularize tumors before surgery or ablation. They are also critical in treating gastrointestinal hemorrhages, renal artery bleeding, and pelvic trauma. Use in neurovascular procedures is well-established, and application in peripheral vascular systems is expanding steadily.

The demand is growing in regions investing in advanced endovascular care. Countries with rising rates of non-communicable diseases, aging populations, and improving access to specialist interventions are driving growth. Integration of embolization into outpatient and day-care protocols is also contributing to higher procedural volumes and adoption of liquid agents.

Growth in the Peripheral Liquid Embolic Agents market is driven by several factors…

Growth in the peripheral liquid embolic agents market is driven by increasing incidence of peripheral vascular abnormalities, expanding applications in interventional oncology and trauma management, and continued development of advanced embolic formulations. Rising preference for minimally invasive embolization techniques in both emergency and elective procedures is supporting higher adoption.

Technological improvements in catheter-delivery systems, enhanced imaging compatibility, and wider availability of specialized interventional services are contributing to procedural efficiency and clinical confidence. Development of tailored embolic agents for high-flow lesions, fragile vasculature, and tumor vasculature further supports usage across diverse clinical scenarios. Growth in healthcare infrastructure and specialist training is expected to expand use globally.

SCOPE OF STUDY:

The report analyzes the Peripheral Liquid Embolic Agents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Tube Applicator / Inserter, Tympanostomy Tubes); Material (Silicone Material, Fluoroplastic Material, Titanium Material, Stainless Steel Material); Application (Acute Otitis Media Application, Recurrent Otitis Media with Effusion Application); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• Abbott Laboratories
• Acandis GmbH
• Balt
• Boston Medical Corporation
• Cardiva
• Cook Medical LLC
• Cerenovus (J&J)
• IMBiotechnologies Ltd.
• Johnson & Johnson
• Kaneka Corporation
• Medtronic plc
• Merit Medical Systems
• Meril Life Sciences Pvt. Ltd.
• MicroVention Inc. (Terumo)
• Penumbra, Inc.
• Rapid Medical
• Stryker Corporation
• Terumo Corporation
• Sirtex Medical Limited

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Peripheral Liquid Embolic Agents - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Peripheral Arteriovenous Malformations Spurs Use of Liquid Embolic Agents for Deep Vessel Occlusion
  • Growth in Non-Coil-Based Embolization Techniques Throws the Spotlight on Polymer and Adhesive-Based Liquid Agents
  • OEM Innovation in Non-Adhesive, Ethylene-Vinyl Alcohol (EVOH), and Radiopaque Formulations Enhances Delivery Safety
  • Expansion of Interventional Oncology and Palliative Care Procedures Strengthens Use in Tumor Vessel Blockage
  • Surge in Neurovascular and Spinal Vascular Disorder Treatments Drives Crossover Use in Peripheral Embolization
  • Improved Compatibility With Microcatheters Supports Access to Challenging Vascular Territories
  • OEM Development of On-Demand Polymerizing and Thermosensitive Agents Enhances Occlusion Precision
  • Growth in Liquid Embolic Delivery Training and Technique Standardization Improves Operator Confidence and Adoption
  • Rising Preference for Long-Term Vascular Sealing Promotes Use in Post-Surgical Hemostasis and Recurrence Prevention
  • Integration of Liquid Embolics With Image-Guided Navigation Supports Minimally Invasive, Targeted Therapy
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Peripheral Liquid Embolic Agents Market Analysis of Annual Sales in US$ for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Peripheral Liquid Embolic Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Peripheral Liquid Embolic Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Tube Applicator / Inserter by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Tube Applicator / Inserter by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Tube Applicator / Inserter by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Tympanostomy Tubes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Tympanostomy Tubes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Tympanostomy Tubes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Specialty Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Silicone Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Silicone Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Silicone Material by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Fluoroplastic Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Fluoroplastic Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Fluoroplastic Material by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Titanium Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Titanium Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Titanium Material by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Stainless Steel Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Stainless Steel Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Stainless Steel Material by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Acute Otitis Media Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Acute Otitis Media Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Acute Otitis Media Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Recurrent Otitis Media with Effusion Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Recurrent Otitis Media with Effusion Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Recurrent Otitis Media with Effusion Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Peripheral Liquid Embolic Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 38: USA Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 40: USA 16-Year Perspective for Peripheral Liquid Embolic Agents by Product - Percentage Breakdown of Value Sales for Tube Applicator / Inserter and Tympanostomy Tubes for the Years 2014, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 43: USA 16-Year Perspective for Peripheral Liquid Embolic Agents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 46: USA 16-Year Perspective for Peripheral Liquid Embolic Agents by Material - Percentage Breakdown of Value Sales for Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material for the Years 2014, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 49: USA 16-Year Perspective for Peripheral Liquid Embolic Agents by Application - Percentage Breakdown of Value Sales for Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 52: Canada 16-Year Perspective for Peripheral Liquid Embolic Agents by Product - Percentage Breakdown of Value Sales for Tube Applicator / Inserter and Tympanostomy Tubes for the Years 2014, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 55: Canada 16-Year Perspective for Peripheral Liquid Embolic Agents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 58: Canada 16-Year Perspective for Peripheral Liquid Embolic Agents by Material - Percentage Breakdown of Value Sales for Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material for the Years 2014, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 61: Canada 16-Year Perspective for Peripheral Liquid Embolic Agents by Application - Percentage Breakdown of Value Sales for Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application for the Years 2014, 2025 & 2030
• JAPAN
  • Peripheral Liquid Embolic Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 64: Japan 16-Year Perspective for Peripheral Liquid Embolic Agents by Product - Percentage Breakdown of Value Sales for Tube Applicator / Inserter and Tympanostomy Tubes for the Years 2014, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 67: Japan 16-Year Perspective for Peripheral Liquid Embolic Agents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 70: Japan 16-Year Perspective for Peripheral Liquid Embolic Agents by Material - Percentage Breakdown of Value Sales for Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material for the Years 2014, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 73: Japan 16-Year Perspective for Peripheral Liquid Embolic Agents by Application - Percentage Breakdown of Value Sales for Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application for the Years 2014, 2025 & 2030
• CHINA
  • Peripheral Liquid Embolic Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 74: China Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 76: China 16-Year Perspective for Peripheral Liquid Embolic Agents by Product - Percentage Breakdown of Value Sales for Tube Applicator / Inserter and Tympanostomy Tubes for the Years 2014, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 79: China 16-Year Perspective for Peripheral Liquid Embolic Agents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 82: China 16-Year Perspective for Peripheral Liquid Embolic Agents by Material - Percentage Breakdown of Value Sales for Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material for the Years 2014, 2025 & 2030
  • TABLE 83: China Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 84: China Historic Review for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 85: China 16-Year Perspective for Peripheral Liquid Embolic Agents by Application - Percentage Breakdown of Value Sales for Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application for the Years 2014, 2025 & 2030
• EUROPE
  • Peripheral Liquid Embolic Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Peripheral Liquid Embolic Agents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 88: Europe 16-Year Perspective for Peripheral Liquid Embolic Agents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 91: Europe 16-Year Perspective for Peripheral Liquid Embolic Agents by Product - Percentage Breakdown of Value Sales for Tube Applicator / Inserter and Tympanostomy Tubes for the Years 2014, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 94: Europe 16-Year Perspective for Peripheral Liquid Embolic Agents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 97: Europe 16-Year Perspective for Peripheral Liquid Embolic Agents by Material - Percentage Breakdown of Value Sales for Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material for the Years 2014, 2025 & 2030
  • TABLE 98: Europe Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 100: Europe 16-Year Perspective for Peripheral Liquid Embolic Agents by Application - Percentage Breakdown of Value Sales for Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application for the Years 2014, 2025 & 2030
• FRANCE
  • Peripheral Liquid Embolic Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 101: France Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 102: France Historic Review for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 103: France 16-Year Perspective for Peripheral Liquid Embolic Agents by Product - Percentage Breakdown of Value Sales for Tube Applicator / Inserter and Tympanostomy Tubes for the Years 2014, 2025 & 2030
  • TABLE 104: France Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 105: France Historic Review for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 106: France 16-Year Perspective for Peripheral Liquid Embolic Agents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 107: France Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 108: France Historic Review for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 109: France 16-Year Perspective for Peripheral Liquid Embolic Agents by Material - Percentage Breakdown of Value Sales for Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material for the Years 2014, 2025 & 2030
  • TABLE 110: France Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 111: France Historic Review for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 112: France 16-Year Perspective for Peripheral Liquid Embolic Agents by Application - Percentage Breakdown of Value Sales for Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application for the Years 2014, 2025 & 2030
• GERMANY
  • Peripheral Liquid Embolic Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 113: Germany Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Germany Historic Review for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 115: Germany 16-Year Perspective for Peripheral Liquid Embolic Agents by Product - Percentage Breakdown of Value Sales for Tube Applicator / Inserter and Tympanostomy Tubes for the Years 2014, 2025 & 2030
  • TABLE 116: Germany Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Germany Historic Review for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 118: Germany 16-Year Perspective for Peripheral Liquid Embolic Agents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 119: Germany Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Germany Historic Review for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 121: Germany 16-Year Perspective for Peripheral Liquid Embolic Agents by Material - Percentage Breakdown of Value Sales for Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material for the Years 2014, 2025 & 2030
  • TABLE 122: Germany Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Germany Historic Review for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 124: Germany 16-Year Perspective for Peripheral Liquid Embolic Agents by Application - Percentage Breakdown of Value Sales for Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 125: Italy Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Italy Historic Review for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 127: Italy 16-Year Perspective for Peripheral Liquid Embolic Agents by Product - Percentage Breakdown of Value Sales for Tube Applicator / Inserter and Tympanostomy Tubes for the Years 2014, 2025 & 2030
  • TABLE 128: Italy Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Italy Historic Review for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 130: Italy 16-Year Perspective for Peripheral Liquid Embolic Agents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 131: Italy Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Italy Historic Review for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 133: Italy 16-Year Perspective for Peripheral Liquid Embolic Agents by Material - Percentage Breakdown of Value Sales for Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material for the Years 2014, 2025 & 2030
  • TABLE 134: Italy Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Italy Historic Review for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 136: Italy 16-Year Perspective for Peripheral Liquid Embolic Agents by Application - Percentage Breakdown of Value Sales for Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Peripheral Liquid Embolic Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 137: UK Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 138: UK Historic Review for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 139: UK 16-Year Perspective for Peripheral Liquid Embolic Agents by Product - Percentage Breakdown of Value Sales for Tube Applicator / Inserter and Tympanostomy Tubes for the Years 2014, 2025 & 2030
  • TABLE 140: UK Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 141: UK Historic Review for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 142: UK 16-Year Perspective for Peripheral Liquid Embolic Agents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 143: UK Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 144: UK Historic Review for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 145: UK 16-Year Perspective for Peripheral Liquid Embolic Agents by Material - Percentage Breakdown of Value Sales for Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material for the Years 2014, 2025 & 2030
  • TABLE 146: UK Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 147: UK Historic Review for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 148: UK 16-Year Perspective for Peripheral Liquid Embolic Agents by Application - Percentage Breakdown of Value Sales for Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 149: Spain Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Spain Historic Review for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 151: Spain 16-Year Perspective for Peripheral Liquid Embolic Agents by Product - Percentage Breakdown of Value Sales for Tube Applicator / Inserter and Tympanostomy Tubes for the Years 2014, 2025 & 2030
  • TABLE 152: Spain Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Spain Historic Review for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 154: Spain 16-Year Perspective for Peripheral Liquid Embolic Agents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 155: Spain Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Spain Historic Review for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 157: Spain 16-Year Perspective for Peripheral Liquid Embolic Agents by Material - Percentage Breakdown of Value Sales for Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material for the Years 2014, 2025 & 2030
  • TABLE 158: Spain Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Spain Historic Review for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 160: Spain 16-Year Perspective for Peripheral Liquid Embolic Agents by Application - Percentage Breakdown of Value Sales for Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 161: Russia Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Russia Historic Review for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 163: Russia 16-Year Perspective for Peripheral Liquid Embolic Agents by Product - Percentage Breakdown of Value Sales for Tube Applicator / Inserter and Tympanostomy Tubes for the Years 2014, 2025 & 2030
  • TABLE 164: Russia Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Russia Historic Review for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 166: Russia 16-Year Perspective for Peripheral Liquid Embolic Agents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 167: Russia Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Russia Historic Review for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 169: Russia 16-Year Perspective for Peripheral Liquid Embolic Agents by Material - Percentage Breakdown of Value Sales for Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material for the Years 2014, 2025 & 2030
  • TABLE 170: Russia Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Russia Historic Review for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 172: Russia 16-Year Perspective for Peripheral Liquid Embolic Agents by Application - Percentage Breakdown of Value Sales for Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Rest of Europe Historic Review for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 175: Rest of Europe 16-Year Perspective for Peripheral Liquid Embolic Agents by Product - Percentage Breakdown of Value Sales for Tube Applicator / Inserter and Tympanostomy Tubes for the Years 2014, 2025 & 2030
  • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Rest of Europe Historic Review for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 178: Rest of Europe 16-Year Perspective for Peripheral Liquid Embolic Agents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Europe Historic Review for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 181: Rest of Europe 16-Year Perspective for Peripheral Liquid Embolic Agents by Material - Percentage Breakdown of Value Sales for Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material for the Years 2014, 2025 & 2030
  • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Europe Historic Review for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 184: Rest of Europe 16-Year Perspective for Peripheral Liquid Embolic Agents by Application - Percentage Breakdown of Value Sales for Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Peripheral Liquid Embolic Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 186: Asia-Pacific Historic Review for Peripheral Liquid Embolic Agents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 187: Asia-Pacific 16-Year Perspective for Peripheral Liquid Embolic Agents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Asia-Pacific Historic Review for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 190: Asia-Pacific 16-Year Perspective for Peripheral Liquid Embolic Agents by Product - Percentage Breakdown of Value Sales for Tube Applicator / Inserter and Tympanostomy Tubes for the Years 2014, 2025 & 2030
  • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Asia-Pacific Historic Review for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 193: Asia-Pacific 16-Year Perspective for Peripheral Liquid Embolic Agents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Asia-Pacific Historic Review for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 196: Asia-Pacific 16-Year Perspective for Peripheral Liquid Embolic Agents by Material - Percentage Breakdown of Value Sales for Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material for the Years 2014, 2025 & 2030
  • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Asia-Pacific Historic Review for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 199: Asia-Pacific 16-Year Perspective for Peripheral Liquid Embolic Agents by Application - Percentage Breakdown of Value Sales for Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Peripheral Liquid Embolic Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 200: Australia Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Australia Historic Review for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 202: Australia 16-Year Perspective for Peripheral Liquid Embolic Agents by Product - Percentage Breakdown of Value Sales for Tube Applicator / Inserter and Tympanostomy Tubes for the Years 2014, 2025 & 2030
  • TABLE 203: Australia Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Australia Historic Review for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 205: Australia 16-Year Perspective for Peripheral Liquid Embolic Agents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 206: Australia Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Australia Historic Review for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 208: Australia 16-Year Perspective for Peripheral Liquid Embolic Agents by Material - Percentage Breakdown of Value Sales for Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material for the Years 2014, 2025 & 2030
  • TABLE 209: Australia Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Australia Historic Review for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 211: Australia 16-Year Perspective for Peripheral Liquid Embolic Agents by Application - Percentage Breakdown of Value Sales for Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application for the Years 2014, 2025 & 2030
• INDIA
  • Peripheral Liquid Embolic Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 212: India Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 213: India Historic Review for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 214: India 16-Year Perspective for Peripheral Liquid Embolic Agents by Product - Percentage Breakdown of Value Sales for Tube Applicator / Inserter and Tympanostomy Tubes for the Years 2014, 2025 & 2030
  • TABLE 215: India Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 216: India Historic Review for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 217: India 16-Year Perspective for Peripheral Liquid Embolic Agents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 218: India Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 219: India Historic Review for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 220: India 16-Year Perspective for Peripheral Liquid Embolic Agents by Material - Percentage Breakdown of Value Sales for Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material for the Years 2014, 2025 & 2030
  • TABLE 221: India Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 222: India Historic Review for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 223: India 16-Year Perspective for Peripheral Liquid Embolic Agents by Application - Percentage Breakdown of Value Sales for Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 224: South Korea Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 225: South Korea Historic Review for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 226: South Korea 16-Year Perspective for Peripheral Liquid Embolic Agents by Product - Percentage Breakdown of Value Sales for Tube Applicator / Inserter and Tympanostomy Tubes for the Years 2014, 2025 & 2030
  • TABLE 227: South Korea Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 228: South Korea Historic Review for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 229: South Korea 16-Year Perspective for Peripheral Liquid Embolic Agents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 230: South Korea Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 231: South Korea Historic Review for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 232: South Korea 16-Year Perspective for Peripheral Liquid Embolic Agents by Material - Percentage Breakdown of Value Sales for Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material for the Years 2014, 2025 & 2030
  • TABLE 233: South Korea Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 234: South Korea Historic Review for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 235: South Korea 16-Year Perspective for Peripheral Liquid Embolic Agents by Application - Percentage Breakdown of Value Sales for Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 236: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Asia-Pacific Historic Review for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 238: Rest of Asia-Pacific 16-Year Perspective for Peripheral Liquid Embolic Agents by Product - Percentage Breakdown of Value Sales for Tube Applicator / Inserter and Tympanostomy Tubes for the Years 2014, 2025 & 2030
  • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Asia-Pacific Historic Review for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 241: Rest of Asia-Pacific 16-Year Perspective for Peripheral Liquid Embolic Agents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Asia-Pacific Historic Review for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 244: Rest of Asia-Pacific 16-Year Perspective for Peripheral Liquid Embolic Agents by Material - Percentage Breakdown of Value Sales for Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material for the Years 2014, 2025 & 2030
  • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Asia-Pacific Historic Review for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 247: Rest of Asia-Pacific 16-Year Perspective for Peripheral Liquid Embolic Agents by Application - Percentage Breakdown of Value Sales for Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Peripheral Liquid Embolic Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 248: Latin America Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 249: Latin America Historic Review for Peripheral Liquid Embolic Agents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 250: Latin America 16-Year Perspective for Peripheral Liquid Embolic Agents by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 251: Latin America Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Latin America Historic Review for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 253: Latin America 16-Year Perspective for Peripheral Liquid Embolic Agents by Product - Percentage Breakdown of Value Sales for Tube Applicator / Inserter and Tympanostomy Tubes for the Years 2014, 2025 & 2030
  • TABLE 254: Latin America Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Latin America Historic Review for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 256: Latin America 16-Year Perspective for Peripheral Liquid Embolic Agents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 257: Latin America Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Latin America Historic Review for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 259: Latin America 16-Year Perspective for Peripheral Liquid Embolic Agents by Material - Percentage Breakdown of Value Sales for Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material for the Years 2014, 2025 & 2030
  • TABLE 260: Latin America Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Latin America Historic Review for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 262: Latin America 16-Year Perspective for Peripheral Liquid Embolic Agents by Application - Percentage Breakdown of Value Sales for Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 263: Argentina Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Argentina Historic Review for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 265: Argentina 16-Year Perspective for Peripheral Liquid Embolic Agents by Product - Percentage Breakdown of Value Sales for Tube Applicator / Inserter and Tympanostomy Tubes for the Years 2014, 2025 & 2030
  • TABLE 266: Argentina Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Argentina Historic Review for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 268: Argentina 16-Year Perspective for Peripheral Liquid Embolic Agents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 269: Argentina Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Argentina Historic Review for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 271: Argentina 16-Year Perspective for Peripheral Liquid Embolic Agents by Material - Percentage Breakdown of Value Sales for Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material for the Years 2014, 2025 & 2030
  • TABLE 272: Argentina Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Argentina Historic Review for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 274: Argentina 16-Year Perspective for Peripheral Liquid Embolic Agents by Application - Percentage Breakdown of Value Sales for Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 275: Brazil Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Brazil Historic Review for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 277: Brazil 16-Year Perspective for Peripheral Liquid Embolic Agents by Product - Percentage Breakdown of Value Sales for Tube Applicator / Inserter and Tympanostomy Tubes for the Years 2014, 2025 & 2030
  • TABLE 278: Brazil Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Brazil Historic Review for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 280: Brazil 16-Year Perspective for Peripheral Liquid Embolic Agents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 281: Brazil Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Brazil Historic Review for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 283: Brazil 16-Year Perspective for Peripheral Liquid Embolic Agents by Material - Percentage Breakdown of Value Sales for Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material for the Years 2014, 2025 & 2030
  • TABLE 284: Brazil Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Brazil Historic Review for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 286: Brazil 16-Year Perspective for Peripheral Liquid Embolic Agents by Application - Percentage Breakdown of Value Sales for Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 287: Mexico Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Mexico Historic Review for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 289: Mexico 16-Year Perspective for Peripheral Liquid Embolic Agents by Product - Percentage Breakdown of Value Sales for Tube Applicator / Inserter and Tympanostomy Tubes for the Years 2014, 2025 & 2030
  • TABLE 290: Mexico Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Mexico Historic Review for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 292: Mexico 16-Year Perspective for Peripheral Liquid Embolic Agents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 293: Mexico Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Mexico Historic Review for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 295: Mexico 16-Year Perspective for Peripheral Liquid Embolic Agents by Material - Percentage Breakdown of Value Sales for Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material for the Years 2014, 2025 & 2030
  • TABLE 296: Mexico Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Mexico Historic Review for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 298: Mexico 16-Year Perspective for Peripheral Liquid Embolic Agents by Application - Percentage Breakdown of Value Sales for Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 299: Rest of Latin America Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Latin America Historic Review for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 301: Rest of Latin America 16-Year Perspective for Peripheral Liquid Embolic Agents by Product - Percentage Breakdown of Value Sales for Tube Applicator / Inserter and Tympanostomy Tubes for the Years 2014, 2025 & 2030
  • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Latin America Historic Review for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 304: Rest of Latin America 16-Year Perspective for Peripheral Liquid Embolic Agents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Latin America Historic Review for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 307: Rest of Latin America 16-Year Perspective for Peripheral Liquid Embolic Agents by Material - Percentage Breakdown of Value Sales for Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material for the Years 2014, 2025 & 2030
  • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Latin America Historic Review for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 310: Rest of Latin America 16-Year Perspective for Peripheral Liquid Embolic Agents by Application - Percentage Breakdown of Value Sales for Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Peripheral Liquid Embolic Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 311: Middle East Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 312: Middle East Historic Review for Peripheral Liquid Embolic Agents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 313: Middle East 16-Year Perspective for Peripheral Liquid Embolic Agents by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 314: Middle East Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Middle East Historic Review for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 316: Middle East 16-Year Perspective for Peripheral Liquid Embolic Agents by Product - Percentage Breakdown of Value Sales for Tube Applicator / Inserter and Tympanostomy Tubes for the Years 2014, 2025 & 2030
  • TABLE 317: Middle East Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Middle East Historic Review for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 319: Middle East 16-Year Perspective for Peripheral Liquid Embolic Agents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 320: Middle East Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Middle East Historic Review for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 322: Middle East 16-Year Perspective for Peripheral Liquid Embolic Agents by Material - Percentage Breakdown of Value Sales for Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material for the Years 2014, 2025 & 2030
  • TABLE 323: Middle East Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Middle East Historic Review for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 325: Middle East 16-Year Perspective for Peripheral Liquid Embolic Agents by Application - Percentage Breakdown of Value Sales for Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 326: Iran Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Iran Historic Review for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 328: Iran 16-Year Perspective for Peripheral Liquid Embolic Agents by Product - Percentage Breakdown of Value Sales for Tube Applicator / Inserter and Tympanostomy Tubes for the Years 2014, 2025 & 2030
  • TABLE 329: Iran Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Iran Historic Review for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 331: Iran 16-Year Perspective for Peripheral Liquid Embolic Agents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 332: Iran Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Iran Historic Review for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 334: Iran 16-Year Perspective for Peripheral Liquid Embolic Agents by Material - Percentage Breakdown of Value Sales for Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material for the Years 2014, 2025 & 2030
  • TABLE 335: Iran Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Iran Historic Review for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 337: Iran 16-Year Perspective for Peripheral Liquid Embolic Agents by Application - Percentage Breakdown of Value Sales for Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 338: Israel Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Israel Historic Review for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 340: Israel 16-Year Perspective for Peripheral Liquid Embolic Agents by Product - Percentage Breakdown of Value Sales for Tube Applicator / Inserter and Tympanostomy Tubes for the Years 2014, 2025 & 2030
  • TABLE 341: Israel Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Israel Historic Review for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 343: Israel 16-Year Perspective for Peripheral Liquid Embolic Agents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 344: Israel Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Israel Historic Review for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 346: Israel 16-Year Perspective for Peripheral Liquid Embolic Agents by Material - Percentage Breakdown of Value Sales for Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material for the Years 2014, 2025 & 2030
  • TABLE 347: Israel Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Israel Historic Review for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 349: Israel 16-Year Perspective for Peripheral Liquid Embolic Agents by Application - Percentage Breakdown of Value Sales for Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 350: Saudi Arabia Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Saudi Arabia Historic Review for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 352: Saudi Arabia 16-Year Perspective for Peripheral Liquid Embolic Agents by Product - Percentage Breakdown of Value Sales for Tube Applicator / Inserter and Tympanostomy Tubes for the Years 2014, 2025 & 2030
  • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Saudi Arabia Historic Review for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 355: Saudi Arabia 16-Year Perspective for Peripheral Liquid Embolic Agents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Saudi Arabia Historic Review for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 358: Saudi Arabia 16-Year Perspective for Peripheral Liquid Embolic Agents by Material - Percentage Breakdown of Value Sales for Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material for the Years 2014, 2025 & 2030
  • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Saudi Arabia Historic Review for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 361: Saudi Arabia 16-Year Perspective for Peripheral Liquid Embolic Agents by Application - Percentage Breakdown of Value Sales for Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 362: UAE Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 363: UAE Historic Review for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 364: UAE 16-Year Perspective for Peripheral Liquid Embolic Agents by Product - Percentage Breakdown of Value Sales for Tube Applicator / Inserter and Tympanostomy Tubes for the Years 2014, 2025 & 2030
  • TABLE 365: UAE Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 366: UAE Historic Review for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 367: UAE 16-Year Perspective for Peripheral Liquid Embolic Agents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 368: UAE Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 369: UAE Historic Review for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 370: UAE 16-Year Perspective for Peripheral Liquid Embolic Agents by Material - Percentage Breakdown of Value Sales for Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material for the Years 2014, 2025 & 2030
  • TABLE 371: UAE Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 372: UAE Historic Review for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 373: UAE 16-Year Perspective for Peripheral Liquid Embolic Agents by Application - Percentage Breakdown of Value Sales for Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 374: Rest of Middle East Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Rest of Middle East Historic Review for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 376: Rest of Middle East 16-Year Perspective for Peripheral Liquid Embolic Agents by Product - Percentage Breakdown of Value Sales for Tube Applicator / Inserter and Tympanostomy Tubes for the Years 2014, 2025 & 2030
  • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Rest of Middle East Historic Review for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 379: Rest of Middle East 16-Year Perspective for Peripheral Liquid Embolic Agents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Rest of Middle East Historic Review for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 382: Rest of Middle East 16-Year Perspective for Peripheral Liquid Embolic Agents by Material - Percentage Breakdown of Value Sales for Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material for the Years 2014, 2025 & 2030
  • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Rest of Middle East Historic Review for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 385: Rest of Middle East 16-Year Perspective for Peripheral Liquid Embolic Agents by Application - Percentage Breakdown of Value Sales for Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application for the Years 2014, 2025 & 2030
• AFRICA
  • Peripheral Liquid Embolic Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 386: Africa Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Africa Historic Review for Peripheral Liquid Embolic Agents by Product - Tube Applicator / Inserter and Tympanostomy Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 388: Africa 16-Year Perspective for Peripheral Liquid Embolic Agents by Product - Percentage Breakdown of Value Sales for Tube Applicator / Inserter and Tympanostomy Tubes for the Years 2014, 2025 & 2030
  • TABLE 389: Africa Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Africa Historic Review for Peripheral Liquid Embolic Agents by End-Use - Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 391: Africa 16-Year Perspective for Peripheral Liquid Embolic Agents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
  • TABLE 392: Africa Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Africa Historic Review for Peripheral Liquid Embolic Agents by Material - Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 394: Africa 16-Year Perspective for Peripheral Liquid Embolic Agents by Material - Percentage Breakdown of Value Sales for Silicone Material, Fluoroplastic Material, Titanium Material and Stainless Steel Material for the Years 2014, 2025 & 2030
  • TABLE 395: Africa Recent Past, Current & Future Analysis for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Africa Historic Review for Peripheral Liquid Embolic Agents by Application - Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 397: Africa 16-Year Perspective for Peripheral Liquid Embolic Agents by Application - Percentage Breakdown of Value Sales for Acute Otitis Media Application and Recurrent Otitis Media with Effusion Application for the Years 2014, 2025 & 2030

IV. COMPETITION